Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease.
Details
Request a copy Under indefinite embargo.UNIL restricted access
State: Public
Version: Final published version
Serval ID
serval:BIB_E1F9E7037795
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease.
Journal
Clinical Neurophysiology
ISSN
1872-8952 (Electronic)
ISSN-L
1388-2457
Publication state
Published
Issued date
2009
Peer-reviewed
Oui
Volume
120
Number
4
Pages
809-815
Language
english
Notes
Publication types: Clinical Trial ; Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.Publication Status: ppublish
Abstract
OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) has shown promising results in treating Parkinson's disease (PD), but the best values for rTMS parameters are not established. Fifty Hertz rTMS may be superior to 25 Hz rTMS investigated so far. The objective of this study was to determine if 50 Hz rTMS could be delivered safely in PD patients since current safety limits are exceeded.
METHODS: Fifty Hertz rTMS was applied with a circular coil on the primary motor cortex (M1). Stimulation intensity was first tested at 60% rest motor threshold [RMT] and 0.5 s train duration and then increased in 0.5 s steps to 2 s, and by 10% steps to 90% RMT. Multi-channel electromyography (EMG) was recorded to control for signs of increasing time-locked EMG activity including correlates of the spread of excitation and after-discharges, or an increase of M1 excitability. Pre- and post-50 Hz rTMS assessments included EEG, Unified Parkinson Disease Rating Scale (UPDRS), Grooved Pegboard Test, Serial Reaction Time Task (SRTT), Folstein Mini-Mental Status Examination (MMSE) and Verbal Fluency to control for motor and cognitive side effects.
RESULTS: Ten PD patients were investigated. Multi-channel EMG showed no signs of increased time-locked EMG activity including correlates of the spread of excitation and after-discharges, or increased M1 excitability in 9 patients. A PD patient with bi-temporal spikes in the pre-testing EEG had clinical and EMG correlates of spread of excitation at 90% RMT, but no seizure activity. Pre- and post-50 Hz assessment showed no changes. No adverse events were observed. Fifty Hertz rTMS was well tolerated except by 1 patient who wished to terminate the study due to facial muscle stimulation.
CONCLUSION: Fifty Hertz rTMS at an intensity of 90% RMT for 2 s appears safe in patients with PD, but caution should be taken for patients with paroxysmal EEG activity. For this reason, comprehensive screening should include EEG before higher-frequency rTMS is applied.
SIGNIFICANCE: This is the first study to investigate safety of 50 Hz rTMS in humans.
METHODS: Fifty Hertz rTMS was applied with a circular coil on the primary motor cortex (M1). Stimulation intensity was first tested at 60% rest motor threshold [RMT] and 0.5 s train duration and then increased in 0.5 s steps to 2 s, and by 10% steps to 90% RMT. Multi-channel electromyography (EMG) was recorded to control for signs of increasing time-locked EMG activity including correlates of the spread of excitation and after-discharges, or an increase of M1 excitability. Pre- and post-50 Hz rTMS assessments included EEG, Unified Parkinson Disease Rating Scale (UPDRS), Grooved Pegboard Test, Serial Reaction Time Task (SRTT), Folstein Mini-Mental Status Examination (MMSE) and Verbal Fluency to control for motor and cognitive side effects.
RESULTS: Ten PD patients were investigated. Multi-channel EMG showed no signs of increased time-locked EMG activity including correlates of the spread of excitation and after-discharges, or increased M1 excitability in 9 patients. A PD patient with bi-temporal spikes in the pre-testing EEG had clinical and EMG correlates of spread of excitation at 90% RMT, but no seizure activity. Pre- and post-50 Hz assessment showed no changes. No adverse events were observed. Fifty Hertz rTMS was well tolerated except by 1 patient who wished to terminate the study due to facial muscle stimulation.
CONCLUSION: Fifty Hertz rTMS at an intensity of 90% RMT for 2 s appears safe in patients with PD, but caution should be taken for patients with paroxysmal EEG activity. For this reason, comprehensive screening should include EEG before higher-frequency rTMS is applied.
SIGNIFICANCE: This is the first study to investigate safety of 50 Hz rTMS in humans.
Keywords
Aged, Biophysics, Electric Stimulation/adverse effects, Electroencephalography, Electromyography, Evoked Potentials, Motor, Female, Functional Laterality, Humans, Male, Mental Status Schedule, Middle Aged, Motor Cortex/physiopathology, Muscle, Skeletal/innervation, Muscle, Skeletal/physiopathology, Neuropsychological Tests, Parkinson Disease/pathology, Parkinson Disease/therapy, Reaction Time/physiology, Risk Assessment, Transcranial Magnetic Stimulation/adverse effects, Treatment Outcome
Pubmed
Web of science
Create date
08/10/2012 10:40
Last modification date
20/08/2019 17:06
Usage data
